Skip to content
Compounder

Samantha McLemore

Net buying

Patient Capital Management, LLC — managed by Samantha McLemore; US equity positions disclosed quarterly via SEC 13F

Data as of 2026-03-31 (filed 2026-05-14) · Source: SEC EDGAR

Portfolio value$2.74B+6%)
Holdings40
Reporting quarterQ1 2026
Top holdingRoyalty Pharma Plc
Portfolio overview

Patient Capital Management, LLC's most recent 13F filing, for the quarter ended 2026-03-31, reports 40 positions worth $2.74B. The top 5 holdings represent 28% of that value, a broadly diversified portfolio.

The single largest position is Royalty Pharma Plc at 6.4% of the portfolio, followed by Citigroup Inc at 5.9% and Alphabet Inc at 5.6%.

Against the prior quarter, Samantha McLemore opened 4 new positions, exited 4, added to 23, and trimmed 11. The largest new buy was Adobe Inc. The most notable sale was the full exit from Mattel Inc.

Across all 8 quarters on file, Royalty Pharma Plc has appeared in every filing, as has Citigroup Inc. Royalty Pharma Plc currently ranks first by value.

A 13F is filed roughly 45 days after quarter-end and covers only long positions in US-listed equities, so it is a lagging and partial view of the portfolio. Source: SEC EDGAR.

High-conviction
Strike-zone picks

None of Samantha McLemore's tracked holdings are in the strike zone right now.

Valuation as of 2026-07-02; method: conservative Greenwald value band + Owner-Earnings DCF. Position observation, not advice.

Next · is it cheap

Samantha McLemore has no positions in the strike zone right now.

Browse the whole market by value band
Holdings
  • Value$174.8MValuationHolders2Weight (prev→now)5.0% 6.4%
  • Value$160.3MValuationAbove valueHolders9Weight (prev→now)5.8% 5.9%
  • Value$153.6MValuationAbove valueHolders34Weight (prev→now)7.0% 5.6%
  • Value$136.3MValuationAbove valueHolders31Weight (prev→now)5.0% 5.0%
  • Value$131.6MValuationHolders3Weight (prev→now)4.8% 4.8%
  • Value$124.0MValuationAbove valueHolders17Weight (prev→now)4.6% 4.5%
  • Value$118.3MValuationAbove valueHolders14Weight (prev→now)4.7% 4.3%
  • Value$117.5MValuationHolders4Weight (prev→now)3.4% 4.3%
  • Value$108.1MValuationHolders3Weight (prev→now)3.6% 4.0%
  • Value$107.5MValuationHolders4Weight (prev→now)4.6% 3.9%
  • Value$97.9MValuationHolders1Weight (prev→now)2.7% 3.6%
  • Value$97.9MValuationAbove valueHolders27Weight (prev→now)3.6% 3.6%
  • Value$97.5MValuationAbove valueHolders12Weight (prev→now)3.8% 3.6%
  • Value$75.2MValuationAbove valueHolders1Weight (prev→now)1.6% 2.7%
  • Value$72.3MValuationAbove valueHolders10Weight (prev→now)New · 2.6%
  • Value$70.0MValuationAbove valueHolders7Weight (prev→now)2.5% 2.6%
  • Value$69.6MValuationAbove valueHolders2Weight (prev→now)3.9% 2.5%
  • Value$69.0MValuationHolders1Weight (prev→now)3.0% 2.5%
  • Value$67.4MValuationHolders3Weight (prev→now)2.8% 2.5%
  • Value$67.1MValuationHolders3Weight (prev→now)2.9% 2.5%
  • Value$66.1MValuationHolders2Weight (prev→now)1.4% 2.4%
  • Value$55.5MValuationAbove valueHolders8Weight (prev→now)2.4% 2.0%
  • Value$54.0MValuationBelow value· unconf.Holders7Weight (prev→now)0.7% 2.0%
  • Value$54.0MValuationHolders3Weight (prev→now)2.0% 2.0%
  • Value$48.5MValuationHolders3Weight (prev→now)2.1% 1.8%

Showing top 25 of 40 positions

Sources· SEC EDGAR 13F as of 2026-03-31 · filed 2026-05-14

Stay Updated

Curated 13F moves and valuation insights, straight to your inbox.